.134 These recommendations are based
primarily on an observed reduction in overall cardiovascular morbidity and death with aspirin therapy. The
AHA Primary Prevention of Cardiovascular Disease and
Stroke agrees with this recommendation.135 There is no
evidence to suggest that antiplatelet agents other than
aspirin have improved benefit in asymptomatic patients
with carotid atherosclerosis.
Evidence for antithrombotic treatment for secondary
prevention of recurrent stroke in